Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Tranexamic acid for the management of obstetric hemorrhage
Luis D. Pacheco
, Gary D.V. Hankins
, Antonio F. Saad
, Maged M. Costantine
, Giuseppe Chiossi
, George R. Saade
Obstetrics & Gynecology
Research output
:
Contribution to journal
›
Article
›
peer-review
50
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Tranexamic acid for the management of obstetric hemorrhage'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Absence of Evidence
20%
Antifibrinolytic Agents
20%
Bleeding
20%
Blood Loss
20%
Clinical Trials
20%
Decreased Risk
20%
Delivery Time
20%
Endothelial Tissue
20%
Evidence Support
20%
Fibrinolytic Activity
20%
Hemorrhaging Woman
20%
Maternal Mortality
20%
Most Common Cause
20%
Obstetric Hemorrhage
100%
Obstetric Population
20%
Prophylactic Treatment
20%
Randomized Controlled Trial
20%
Risk of Death
20%
Thromboembolic Complications
20%
Tissue Plasminogen Activator (t-PA)
20%
Tranexamic Acid
100%
Transfusion Rate
20%
Trauma Patients
20%
Medicine and Dentistry
Antifibrinolytic
20%
Bleeding
40%
Clinical Trial
20%
Fibrinolysis
20%
Maternal Mortality
20%
Obstetric Hemorrhage
100%
Obstetrics
20%
Randomized Controlled Trial
20%
Thromboembolism
20%
Tissue Plasminogen Activator
20%
Tranexamic Acid
100%
Pharmacology, Toxicology and Pharmaceutical Science
Antifibrinolytic Agent
20%
Bleeding
40%
Clinical Trial
20%
Fibrinolytic Agent
20%
Maternal Mortality
20%
Obstetric Hemorrhage
100%
Randomized Controlled Trial
20%
Thromboembolism
20%
Tissue Plasminogen Activator
20%
Tranexamic Acid
100%